Related references
Note: Only part of the references are listed.An investigation into the identification of potential inhibitors of SARS-CoV-2 main protease using molecular docking study
Sourav Das et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)
Identification of bioactive molecule fromWithania somnifera(Ashwagandha) as SARS-CoV-2 main protease inhibitor
Manish Kumar Tripathi et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)
In-Silico approach for identification of effective and stable inhibitors for COVID-19 main protease (Mpro) from flavonoid based phytochemical constituents ofCalendula officinalis
Pratik Das et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)
Evaluation of green tea polyphenols as novel corona virus (SARS CoV-2) main protease (Mpro) inhibitors - anin silicodocking and molecular dynamics simulation study
Rajesh Ghosh et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)
Identification of alkaloids from Justicia adhatoda as potent SARS CoV-2 main protease inhibitors: An in silico perspective
Rajesh Ghosh et al.
JOURNAL OF MOLECULAR STRUCTURE (2021)
Phenylbenzopyrone of Flavonoids as a Potential Scaffold to Prevent SARS-CoV-2 Replication by Inhibiting its MPRO Main Protease
Angamba M. Potshangbam et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2021)
Glycyrrhizin Effectively Inhibits SARS-CoV-2 Replication by Inhibiting the Viral Main Protease
Lukas van de Sand et al.
VIRUSES-BASEL (2021)
A new coronavirus associated with human respiratory disease in China
Fan Wu et al.
NATURE (2020)
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Peng Zhou et al.
NATURE (2020)
A Novel Coronavirus from Patients with Pneumonia in China, 2019
Na Zhu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia
Qun Li et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
SARS-CoV-2: Recent Reports on Antiviral Therapies Based on Lopinavir/Ritonavir, Darunavir/Umifenovir, Hydroxychloroquine, Remdesivir, Favipiravir and other Drugs for the Treatment of the New Coronavirus
Michele Costanzo et al.
CURRENT MEDICINAL CHEMISTRY (2020)
Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease
Wenhao Dai et al.
SCIENCE (2020)
Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors
Linlin Zhang et al.
SCIENCE (2020)
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
Fei Zhou et al.
LANCET (2020)
Rapid Identification of Potential Inhibitors of SARS-CoV-2 Main Protease by Deep Docking of 1.3 Billion Compounds
Anh-Tien Ton et al.
MOLECULAR INFORMATICS (2020)
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19
B. Cao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Structural stability of SARS-CoV-2 3CLpro and identification of quercetin as an inhibitor by experimental screening
Olga Abian et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2020)
Virtual screening and repurposing of FDA approved drugs against COVID-19 main protease
Mahmoud Kandeel et al.
LIFE SCIENCES (2020)
Andrographolide and its fluorescent derivative inhibit the main proteases of 2019-nCoV and SARS-CoV through covalent linkage
Tzu-Hau Shi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
Progress in Studies on Structural and Remedial Aspects of Newly Born Coronavirus, SARS-CoV-2
Satya P. Gupta
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2020)
Protease Inhibitory Effect of Natural Polyphenolic Compounds on SARS-CoV-2: An In Silico Study
Rajveer Singh et al.
MOLECULES (2020)
Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication
Wayne Vuong et al.
NATURE COMMUNICATIONS (2020)
In silico analysis of selected alkaloids against main protease (Mpro) of SARS-CoV-2
Saksham Garg et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2020)
Repurposing of known anti-virals as potential inhibitors for SARS-CoV-2 main protease using molecular docking analysis
Mohammed Hakmi et al.
BIOINFORMATION (2020)
In silico high-throughput virtual screening and molecular dynamics simulation study to identify inhibitor for AdeABC efflux pump of Acinetobacter baumannii
Privita Verma et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2018)
Potent inhibition of norovirus 3CL protease by peptidyl α-ketoamides and α-ketoheterocycles
Sivakoteswara Rao Mandadapu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Broad-Spectrum Antivirals against 3C or 3C-Like Proteases of Picornaviruses, Noroviruses, and Coronaviruses
Yunjeong Kim et al.
JOURNAL OF VIROLOGY (2012)
Design, synthesis, and evaluation of inhibitors of Norwalk virus 3C protease
Kok-Chuan Tiew et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Natural products in drug discovery
Alan L. Harvey
DRUG DISCOVERY TODAY (2008)
Share Paper
